TET2 in epigenetic control of immune cells: Implications for inflammatory responses and age-related pathologies
Open Access
- 6 February 2026
- journal article
- review article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (3) , 111267
Abstract
No abstract availableKeywords
Funding Information
- Narodowe Centrum Nauki (2020/37/B/NZ2/03268)
- ERA-Net NEURON
- Narodowym Centrum Nauki
- Narodowe Centrum Badań i Rozwoju (NeuronC2/II/34/CH-Stroke/2023)
This publication has 127 references indexed in Scilit:
- DNA demethylase Tet2 promotes the terminal maturation of natural killer cellsImmunologic Research, 2024
- Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinomaHepatology, 2023
- NFAT1 Orchestrates Spinal Microglial Transcription and Promotes Microglial Proliferation via c‐MYC Contributing to Nerve Injury‐Induced Neuropathic PainAdvanced Science, 2022
- Mechanisms that regulate the activities of TET proteinsCellular and Molecular Life Sciences, 2022
- TET2-Driven Clonal Hematopoiesis and Response to CanakinumabJAMA Cardiology, 2022
- Regulation of TET2 gene expression and 5mC oxidation in breast cancer cells by estrogen signalingBiochemical and Biophysical Research Communications, 2022
- The function and regulation of TET2 in innate immunity and inflammationProtein & Cell, 2020
- Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignanciesCancer Letters, 2019
- Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart FailureJAMA Cardiology, 2019
- TET2 Deficiency Inhibits Mesoderm and Hematopoietic Differentiation in Human Embryonic Stem CellsStem Cells, 2014